Heart podcast
Summary: From June 2023, all our podcasts will move to https://heartbmj.podbean.com. You can continue with your subscription on your favourite podcast App. Heart is an international, peer-reviewed journal that keeps cardiologists up to date with advances in the diagnosis and treatment of cardiovascular disease. Each issue contains original research, accompanying editorials and reviews. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
- Visit Website
- RSS
- Artist: BMJ Group
- Copyright: 643134
Podcasts:
Editor-in-Chief Dr Catherine Otto talks to Dr Carolyn Lam at the Cardiac Society of Australia & New Zealand meeting in Melbourne. They discuss her session on heart failure with preserved ejection fraction.
Editor-in-Chief Dr Catherine Otto talks to Dr David Calemajer at the Cardiac Society of Australia & New Zealand meeting in Melbourne. They discuss his session on managing the large spectrum of Ebstein's anomaly in adults in the absence of RCT data.
Editor-in-Chief Dr Catherine Otto talks to Dr David Calemajer at the Cardiac Society of Australia & New Zealand meeting in Melbourne. They discuss his session on managing the large spectrum of Ebstein's anomaly in adults in the absence of RCT data.
Alistair Lindsey talks to Martin Hülsmann and Noemi Pavo, both from the Medical University of Vienna, about their paper examining cardiovascular biomarkers in cancer patients. Paper: http://heart.bmj.com/content/early/2015/09/08/heartjnl-2015-307848.abstract
Alistair Lindsey talks to Martin Hülsmann and Noemi Pavo, both from the Medical University of Vienna, about their paper examining cardiovascular biomarkers in cancer patients. Paper: http://heart.bmj.com/content/early/2015/09/08/heartjnl-2015-307848.abstract
Chocolate is an important dietary source of flavonoid antioxidants, which are hypothesised to have a beneficial effect on endothelial function and protect against cardiovascular disease (CVD). In this podcast Dr Alistair Lindsay talks to Dr Phyo K Myint about his team's research into this topic. In order to evaluate any association between habitual chocolate consumption and the risk of cardiovascular events, they analysed data from the European Prospective Investigation into Cancer-Norfolk (EPIC-Norfolk), and incorporated the results from this observational study into the evidence available to date.
Chocolate is an important dietary source of flavonoid antioxidants, which are hypothesised to have a beneficial effect on endothelial function and protect against cardiovascular disease (CVD). In this podcast Dr Alistair Lindsay talks to Dr Phyo K Myint about his team's research into this topic. In order to evaluate any association between habitual chocolate consumption and the risk of cardiovascular events, they analysed data from the European Prospective Investigation into Cancer-Norfolk (EPIC-Norfolk), and incorporated the results from this observational study into the evidence available to date.
Aortic valve stenosis (AS) is a progressive disease, but the impact of baseline AS haemodynamic or anatomic severity on AS progression remains unclear. In this podcast Dr Alistair Lindsay talks to Dr Virginia Nguyen about her study to evaluate the impact of baseline AS severity assessed, either by using echocardiography (haemodynamic assessment) or MSCT (anatomic assessment) on AS progression.
Aortic valve stenosis (AS) is a progressive disease, but the impact of baseline AS haemodynamic or anatomic severity on AS progression remains unclear. In this podcast Dr Alistair Lindsay talks to Dr Virginia Nguyen about her study to evaluate the impact of baseline AS severity assessed, either by using echocardiography (haemodynamic assessment) or MSCT (anatomic assessment) on AS progression.
Percutaneous Coronary Intervention (PCI) has a considerable evidence base and it is firmly established as the most common procedure used in the invasive treatment of patients with CHD in the UK. The evidence base relating to PCI has been reviewed and this has been published in Heart. The guidelines focus on issues pertinent to practice within the UK and set out a recommended template to ensure optimal delivery of patient care. Dr Alistair Lindsay speaks to Professor Adrian Banning from the John Radcliffe Hospital at the University of Oxford who was co-author on the guidelines.
Percutaneous Coronary Intervention (PCI) has a considerable evidence base and it is firmly established as the most common procedure used in the invasive treatment of patients with CHD in the UK. The evidence base relating to PCI has been reviewed and this has been published in Heart. The guidelines focus on issues pertinent to practice within the UK and set out a recommended template to ensure optimal delivery of patient care. Dr Alistair Lindsay speaks to Professor Adrian Banning from the John Radcliffe Hospital at the University of Oxford who was co-author on the guidelines.
Dr Alistair Lindsay speaks to Dr Tomasz Baron about his research which aimed to assess differences in incidence, clinical features, current treatment strategies and outcome in patients with type 2 vs. type 1 acute myocardial infarction (AMI). Full paper found here >> http://heart.bmj.com/content/101/2/101.full?sid=e9538ca9-604b-40af-95a7-c03f016f4c2e
Dr Alistair Lindsay speaks to Dr Tomasz Baron about his research which aimed to assess differences in incidence, clinical features, current treatment strategies and outcome in patients with type 2 vs. type 1 acute myocardial infarction (AMI). Full paper found here >> http://heart.bmj.com/content/101/2/101.full?sid=e9538ca9-604b-40af-95a7-c03f016f4c2e
Frailty in older age is known to be associated with cardiovascular disease (CVD) risk. However, the extent to which frailty is associated with the CVD risk profile has been little studied. Dr Alistair Lindsay talked to Dr Sheena Ramsay about her study and the clinical implications of the results.The original paper can be found here: http://heart.bmj.com/content/101/8/616.full?sid=767613b9-71bb-41af-80e8-361647c03828
Frailty in older age is known to be associated with cardiovascular disease (CVD) risk. However, the extent to which frailty is associated with the CVD risk profile has been little studied. Dr Alistair Lindsay talked to Dr Sheena Ramsay about her study and the clinical implications of the results.The original paper can be found here: http://heart.bmj.com/content/101/8/616.full?sid=767613b9-71bb-41af-80e8-361647c03828
